Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer

Ferlay, 2013 Nagini, 2012, Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention, World J Gastrointest Oncol, 4, 156, 10.4251/wjgo.v4.i7.156 Lee, 2013, Environmental and lifestyle risk factors of gastric cancer, Arch Iran Med, 16, 358 Labrie, 2001, DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology, Front Neuroendocrinol, 22, 185, 10.1006/frne.2001.0216 Labrie, 1991, Intracrinology, Mol Cell Endocrinol, 78, C113, 10.1016/0303-7207(91)90116-A Brodie, 2009, The Coffey lecture: steroidogenic enzyme inhibitors and hormone dependent cancer, Urol Oncol, 27, 53, 10.1016/j.urolonc.2008.07.036 Luu-The, 2001, Analysis and characteristics of multiple types of human 17-hydroxysteroid dehydrogenase, J Steroid Biochem Mol Biol, 76, 143, 10.1016/S0960-0760(00)00155-2 Labrie, 1997, The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology, Steroids, 62, 148, 10.1016/S0039-128X(96)00174-2 Frycz, 2013, Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer, Biomed Pharmacother, 67, 651, 10.1016/j.biopha.2013.06.012 Labrie, 2000, Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues, Trends Endocrinol Metab, 11, 421, 10.1016/S1043-2760(00)00342-8 Gan, 2012, Expression profile and prognostic role of sex hormone receptors in gastric cancer, BMC Cancer, 2, 566, 10.1186/1471-2407-12-566 Oduwole, 2003, Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissues, Anticancer Res, 23, 3889 Nakamura, 2006, In situ androgen production in human gastric carcinoma – androgen synthesizing and metabolizing enzymes, Anticancer Res, 26, 1935 Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 Radonić, 2004, Guideline to reference gene selection for quantitative real-time PCR, Biochem Biophys Res Commun, 313, 856, 10.1016/j.bbrc.2003.11.177 Izawa, 2008, Cytochrome P450 aromatase gene (CYP19) expression in gastric cancer, Gastric Cancer, 11, 103, 10.1007/s10120-008-0463-x Camargo, 2012, Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis, Cancer Epidemiol Biomarkers Prev, 21, 20, 10.1158/1055-9965.EPI-11-0834 Chandanos, 2008, Oestrogen and the enigmatic male predominance of gastric cancer, Eur J Cancer, 44, 2397, 10.1016/j.ejca.2008.07.031 Lindblad, 2004, Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden, Cancer Epidemiol Biomarkers Prev, 13, 2203, 10.1158/1055-9965.2203.13.12 Duell, 2010, Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition, Am J Epidemiol, 172, 1384, 10.1093/aje/kwq321 Chandanos, 2008, Tamoxifen exposure in relation to gastric adenocarcinoma development, Eur J Cancer, 44, 1007, 10.1016/j.ejca.2008.02.049 Matsuyama, 2000, Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan, Ann Oncol, 11, 1537, 10.1093/oxfordjournals.annonc.a010406 Sheh, 2011, 17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice, Cancer Prev Res, 4, 1426, 10.1158/1940-6207.CAPR-11-0219 Ohtani, 2011, 17β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice, Carcinogenesis, 32, 1244, 10.1093/carcin/bgr072 Ohtani, 2007, Protective role of 17beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice, Carcinogenesis, 28, 2597, 10.1093/carcin/bgm150 Campbell-Thompson, 1999, 17beta-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N′-nitro-nitrosoguanidine, Endocrinology, 140, 4886, 10.1210/endo.140.10.7030 Nylander-Koski, 2007, The effect of nitric oxide, growth factors, and estrogen on gastric cell migration, J Surg Res, 143, 230, 10.1016/j.jss.2006.12.002 Pricci, 2001, Effects of 17beta-estradiol administration on apoptosis and polyamine content in AGS cell line, Anticancer Res, 21, 3215 Harrison, 1990, A study on the effects of estradiol and estramustine on gastrointestinal cell lines, Eur J Surg Oncol, 16, 116 Harrison, 1989, The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines, Cancer, 63, 2148, 10.1002/1097-0142(19890601)63:11<2148::AID-CNCR2820631113>3.0.CO;2-C Cooper, 2014, Androgens and prostate disease, Asian J Androl, 16, 248, 10.4103/1008-682X.122361 Wang, 2004, Androgens and ovarian cancers, Eur J Gynaecol Oncol, 25, 157 Saitoh, 1992, De novo expression of aromatase in gastric carcinoma. Light and electron microscopic immunohistochemical and immunoblot study, Pathol Res Pract, 188, 53, 10.1016/S0344-0338(11)81156-8 Tian, 2013, Androgen receptor may be responsible for gender disparity in gastric cancer, Med Hypotheses, 80, 672, 10.1016/j.mehy.2013.01.023 Kominea, 2004, Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer, J Cancer Res Clin Oncol, 130, 253, 10.1007/s00432-003-0531-x Hsing, 2001, Hormones and prostate cancer: what's next?, Epidemiol Rev, 23, 42, 10.1093/oxfordjournals.epirev.a000795 Frycz, 2014, Expressions of genes encoding steroidogenic enzymes and their role in prostate carcinogenesis, Nowiny Lekarskie, 83, 73 Hsing, 2002, Hormones and prostate cancer: current perspectives and future directions, Prostate, 52, 213, 10.1002/pros.10108